
News • Polycystic ovary syndrome
Study links PCOS and heart disease
Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to new research.

From gynaecology to obstetrics, from breast cancer treatments to menopause research: the distinct medical needs of female patients are manifold. But also in many other areas of research, diagnostics and therapy, the awareness of women requiring different approaches than male patients is dawning.

Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to new research.

Endometriosis affects up to one in ten women and girls of reproductive age, but for many, the path to diagnosis is both long and complex. Now, two new studies explain the diagnostic challenges in primary care.

After 15 years of HPV vaccination programmes across Europe, growing evidence confirms their long-term effectiveness. A new report highlights steady progress in cancer prevention efforts.

Repeated menstrual cycles may do more than trigger endometriosis – they may rewire the brain, a new study finds. Recurring inflammation can sensitize the nervous system, driving lasting pain.

As women age, their breast tissue goes through major changes, with the most dramatic changes at menopause, but also during pregnancy and childbirth. A map reveals the impact on breast cancer.

Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a new international study.

Study shows women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis – compared to under 20% for those not detected through screening.

“Each pregnancy leaves a unique mark on the female brain”: Research shows that mothers' brains distinctly change, not just during the first pregnancy, to better care for multiple children.

Severe headache, neck pain or confusion: More than 25% of pregnant women suffering non-specific stroke symptoms sought care but were misdiagnosed, University of Pittsburgh research finds.

Women who had a stroke caused by blocked blood vessels (ischemic stroke) are twice as likely to have another stroke during pregnancy and within six weeks of childbirth, according to a new study.

Siemens Healthineers, with funding from the Gates Foundation, plans to develop artificial intelligence (AI) to enable earlier prediction of pre-eclampsia and anemia in low-resource settings.

A first-time mother has about a 30% chance of complication in the second stage of labour, requiring assisted delivery or emergency C-section. A new device could help reduce birth trauma.

A first-of-its-kind study could lead to quicker and more targeted support for vulvodynia - a painful chronic condition estimated to affect more than one in 10 women with no known cause.

Many women over 50 schedule mammograms for breast cancer but miss out on CT lung cancer screenings they're also eligible for. Targeted outreach coul help change this, a new study shows.

The contraceptive pill may negatively affect women's mental health, a new study suggests. Women who are genetically predisposed to mental illness are particularly at risk.

Breast cancer – including aggressive variants – are surprisingly common in younger women, a new study shows. The findings strengthen the case for earlier, risk-tailored screening, the authors say.

While saving lives remains the primary goal, a new study explores how radiation therapy also helps breast cancer survivors return to work. Policymakers should factor this in, the researchers argue.

Dunlee will present its portfolio of integrated imaging solutions at RSNA 2025 in Chicago, Illinois. The company will demonstrate technologies for diagnostic and therapeutic imaging applications, including developments in Ultra-High Resolution and Photon Counting CT (UHR & PCCT), components for MRI-guided breast biopsies, and onboard imaging systems for radiation therapy.

More than a decade of protection against the human papillomavirus (HPV): a new study confirms the long-term effectiveness of the HPV vaccine to prevent development of cervical cancer and pre-cancer.